Friday, Mar 29, 2024
engineered enzymes for better healthcare

Enzolve Technologies, a UCD spin-out company, has formally launched its first CE-marked diagnostic test, which screens for phenylketonuria (PKU) in newborn babies. Enzolve's PKU test, based on engineered enzyme technology, has several advantages over the tests currently available on the market...

Read full article on the web   Irish Medical News May 15, 2009  or in pdf format   pdf_button

 

  Back to the News page 

Language Selection

Search